Dr. Van Hasselt Charles Andrew - Otorhinolaryngology
Specialist in Otorhinolaryngology
Highlights
- MCHK RegisteredVerified
- Consultation LanguageEnglish
- 1 LocationsMa Liu Shui
- Specialist in OtorhinolaryngologyFellow of the Royal College of Surgeons of Edinburgh · Fellow of the Royal College of Surgeons of England · Earliest qualification 1994
- InsuranceBeing compiled|See details
About
Dr. Van Hasselt Charles Andrew practises Otorhinolaryngology in Ma Liu Shui, Hong Kong. They speaks English.
Education
Specialist in Otorhinolaryngology
- Fellow of the Royal College of Surgeons of EdinburghFellow of the Royal College of Surgeons of Edinburgh1994
- Fellow of the Royal College of Surgeons of EnglandFellow of the Royal College of Surgeons of England1999
Locations
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Van Hasselt Charles Andrew? Claim page and update insurance →
FAQ
Is Dr. Van Hasselt Charles Andrew any good?
Dr. Van Hasselt Charles Andrew practises Otorhinolaryngology in Ma Liu Shui, Hong Kong. They speaks English. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Van Hasselt Charles Andrew do?
Dr. Van Hasselt Charles Andrew practises in Otorhinolaryngology.
Where does Dr. Van Hasselt Charles Andrew practise?
Dr. Van Hasselt Charles Andrew practises at Ma Liu Shui.
What languages does Dr. Van Hasselt Charles Andrew speak?
Dr. Van Hasselt Charles Andrew speaks English.
Are you Dr. Van Hasselt Charles Andrew? Claim this page to update and manage.
ClaimResearch and publications
3 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- The role of Nrf2 in anoikis resistance and metastasis in anaplastic thyroid carcinoma.Molecular biomedicine · 2025
- Targeting Nrf2 to treat thyroid cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
- Autophagy regulates anti-angiogenic property of lenvatinib in thyroid cancer.American journal of cancer research · 2023
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer